iStock-1172124252.jpg
GEL_logo_RGB_Light.png

Genomic Healthcare & Research Summit 

Business Design Centre, London, 4-5 May 2022

 

Discover

What we're working on and how we can help you to accelerate your research.

View the programme >

CONNECT

Talk to the people who can help you achieve your research goals. 

See who's attending >

learn

Take part in workshops and interactive sessions put together by experts to tackle the tough problems.

Sign up for workshops >

CONTRIBUTE

Be part of the conversation that's shaping the future of genomic healthcare through roundtables, panels and more.

See how you can take part >

Shaping the future of healthcare, together with industry partners

We are entering a new phase of the 100K genomes project where we are increasingly collaborating, seeking input, and engaging with industry partners. We welcome you to spend the day getting to know more about our new team and strategy, and how you or your organisation could help us build the future of healthcare.

DF7 is on online event. We'll be taking questions and comments throughout the day and our team will be interacting in the chatroom.  

 
Speakers
More to be announced soon
Session info

Genomics England and Discovery Forum: 2021 and beyond 

 

This session will kick off the day with an introduction to our new team, strategy and culture, as well as the new services offered by GEL and the Discovery Forum.  

 

Engage with our leadership team in a Q&A session where they will be taking questions and comments from the audience. 

Keynote talk: pharma case study

 

Hear from one our top pharmaceutical partners to learn how they have worked with Genomics England to advance drug discovery programmes.

Update on the NHS Genomic Medicine Service 

 

Together with the NHS and partners, Genomics England has been working to harness the power of genomic technology and science to improve the health of our population. The Genomic Medicine Service (GMS) is the world's first national health care programme to offer whole genome sequencing as part of routine care. The GMS will enable life-changing results for rare disease and cancer patients offered the service. Genomics England and the NHS are seeking to sequence 500,000 whole genomes by 2023/24 through the service. 

 

This session covers the latest project developments, as well as the key challenges and impact, both already achieved and planned for the future. 

Working with our participants: an engagement strategy session 

 

With the NHS GMS programme’s goal of sequencing 500,000 whole genomes by 2023/24, we want to ensure we are maintaining an open dialogue with our sequencing programme participants. We currently work closely with a Participant Panel, who will have representatives at this session to discuss how we continue to build on the current relationship with the Panel to keep participant interests at the forefront of the project goals.   

Delivering world-class research

 

We will present the most exciting results from our recent research efforts on Covid-19, cancer and rare diseases. We will also present our new cutting-edge Research Environment, built in collaboration with LifeBit, and showcase its capabilities to illustrate just how this powerful platform can be for genomic research, followed by an extensive Q&A session where you can discuss your bioinformatic needs and challenges with our experts 

A glimpse into the future: Genomics England’s Innovation programmes 

 

Hear about, and input on, the next steps for the big topics we’re tackling. We’ll discuss our commitment to increasing the diversity of our data and making genomic medicine accessible to everyone. We’ll be covering the next steps and longer ambitions for our main innovation programmes with a focus on the work we’re doing to: 

  1. Explore the potential for whole genome sequencing at birth to increase the diagnosis and improve long term outcomes of genetic conditions. 
     

  2. Introduce long-read & methylation sequencing for cancer patients, as well as digital radiology and pathology images alongside genomic data to create the largest multimodal cancer dataset in the world. 

Register
Get in touch

 

Thanks for submitting!